APA (7th ed.) Citation

J, Y., F, S., M, Z., M, Z., W, S., S, J., . . . G, W. (2026). Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: A multicenter retrospective study. BMC medicine, 24(1), . https://doi.org/10.1186/s12916-026-04755-6

Chicago Style (17th ed.) Citation

J, Yu, et al. "Anti-CD19 Chimeric Antigen Receptor T-cell Therapy for Relapsed or Refractory Philadelphia Chromosome-positive B Cell Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study." BMC Medicine 24, no. 1 (2026). https://doi.org/10.1186/s12916-026-04755-6.

MLA (9th ed.) Citation

J, Yu, et al. "Anti-CD19 Chimeric Antigen Receptor T-cell Therapy for Relapsed or Refractory Philadelphia Chromosome-positive B Cell Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study." BMC Medicine, vol. 24, no. 1, 2026, https://doi.org/10.1186/s12916-026-04755-6.